Evive Health and Workplace Influenza Vaccinations Custom Case Solution & Analysis

Evidence Brief: Case Extraction

Financial Metrics

  • Annual direct cost of influenza to United States employers: 10.4 billion dollars.
  • Total annual economic burden of influenza in the United States: 87 billion dollars.
  • Loss of productivity due to influenza: 17 million workdays annually.
  • Evive Health revenue model: Per Member Per Month (PMPM) fees charged to employers or health plans.
  • Field experiment scale: 11067 employees at a large Midwestern utility company.
  • Cost per vaccination at workplace clinics: Historically lower than off-site private clinics.

Operational Facts

  • Intervention method: One-time mailings sent to employee residences.
  • Control group size: 2435 employees who received no mailing.
  • Treatment groups: Five variations of mailings tested across 8632 employees.
  • Data source: Integration of daily health claim feeds and pharmacy data.
  • Company location: Chicago, Illinois.
  • Technology: Proprietary predictive analytics engine to identify gaps in care.

Stakeholder Positions

  • Prashant Srivastava: Chief Operating Officer and Co-founder, focused on the efficacy of behavioral nudges.
  • Peter Saravis: Chief Executive Officer and Co-founder, concerned with scaling the business model beyond seasonal interventions.
  • Employer Partner: Large Midwestern utility company seeking to reduce absenteeism and healthcare expenditures.
  • Employees: The target population whose behavior (vaccination) is the primary outcome variable.

Information Gaps

  • The specific PMPM dollar amount charged to the Midwestern utility company is not stated.
  • The long-term retention rate of health behaviors after the initial nudge is not provided.
  • The exact cost of printing and mailing each physical intervention is omitted.
  • The internal rate of return for the employer based on the 2012 experiment results is not calculated in the text.

Strategic Analysis

Core Strategic Question

  • How can Evive Health transition from a seasonal flu-shot reminder service into a year-round integrated health platform that commands higher PMPM fees?
  • What is the optimal balance between physical mailings and digital communications to maximize behavior change while minimizing operational costs?

Structural Analysis

The Jobs-to-be-Done framework reveals that employers do not buy messaging; they buy the reduction of avoidable medical claims and absenteeism. Evive Health addresses the gap between health insurance coverage and employee action. However, the Bargaining Power of Buyers is high because large employers can choose between various wellness vendors. The Threat of Substitutes is significant as health insurance carriers are building their own internal nudge capabilities.

Strategic Options

Option 1: The Chronic Care Pivot. Shift focus from seasonal influenza to high-cost chronic conditions like diabetes and hypertension. This increases the value proposition from a one-time event to year-round management.
Trade-offs: Requires deeper data integration and higher clinical expertise.
Resources: Enhanced data science team and clinical consultants.

Option 2: Digital-First Transformation. Phase out physical mailers in favor of a mobile application and SMS-based nudges.
Trade-offs: Lower cost of goods sold but risks lower engagement among older workforce demographics.
Resources: Software development and UX design investment.

Preliminary Recommendation

Evive Health must pursue Option 1. The influenza experiment proves the efficacy of the nudge, but the financial impact of flu is small compared to chronic disease. By applying the same behavioral economics to medication adherence and regular screenings, Evive can justify a 3x increase in PMPM fees. The company must move from being a tactical vendor to a strategic partner in population health management.

Implementation Roadmap

Critical Path

  • Month 1: Audit existing claims data to identify the top three chronic cost drivers for the current client base.
  • Month 2: Design behavioral nudge sequences for medication adherence and specialist visits based on the successful planning-prompt templates from the flu study.
  • Month 3: Secure a pilot program with an existing large employer to test chronic care nudges.
  • Month 4: Integrate real-time pharmacy data feeds to trigger nudges immediately upon a missed refill.

Key Constraints

  • Data Latency: Claims data often arrives with a 30 to 60 day lag, which renders nudges for immediate actions ineffective.
  • Regulatory Compliance: Strict adherence to HIPAA and state-level privacy laws regarding sensitive chronic health data.
  • Employee Trust: The risk of employees perceiving employer-sponsored health nudges as invasive surveillance.

Risk-Adjusted Implementation Strategy

The transition will follow a phased rollout. To mitigate data latency, Evive will prioritize pharmacy data over medical claims data, as pharmacy triggers are more frequent and timely. To address privacy concerns, all communications will emphasize employee benefit and remain strictly opt-out. The plan includes a 15 percent buffer in the development timeline to account for the complexity of integrating diverse data formats from different insurance carriers.

Executive Review and BLUF

BLUF

Evive Health must pivot from seasonal flu interventions to chronic disease management to secure long-term viability. The 2012 experiment confirms that personalized nudges increase vaccination rates, but flu shots alone cannot sustain a high-margin PMPM model. The path forward requires applying these behavioral insights to high-cost, year-round health issues like diabetes and cardiovascular health. This shift transforms Evive from a niche messaging service into a critical component of the employer healthcare value chain. Success depends on reducing data latency and expanding the nudge library to address complex health behaviors.

Dangerous Assumption

The analysis assumes that the high response rate to physical mailers for a simple, one-time action like a flu shot will translate to complex, repetitive behaviors required for chronic disease management. Behavioral economics suggests that the friction for daily medication adherence is significantly higher than for a single annual injection.

Unaddressed Risks

  • Platform Saturation: As Evive expands the number of nudges, employees may experience notification fatigue, leading to a decline in overall engagement across all health categories. (Probability: High; Consequence: Moderate)
  • Disintermediation by Carriers: Health insurance providers like Aetna or UnitedHealth may integrate similar behavioral nudges directly into their portals, rendering third-party platforms like Evive redundant. (Probability: Moderate; Consequence: Critical)

Unconsidered Alternative

The team did not evaluate a B2C model. Instead of selling to employers, Evive could partner directly with pharmacy benefit managers to nudge consumers at the point of sale or via retail pharmacy apps. This would bypass the slow employer sales cycle and provide access to more immediate behavioral data.

Verdict

APPROVED FOR LEADERSHIP REVIEW


Qualico: Building a Path Forward custom case study solution

On Balance, Who's the Better Manager? custom case study solution

Jazz: The Journey Towards Diversity, Equity, and Inclusion custom case study solution

Robot Rumors: Should I Be Worried? custom case study solution

M&A Deal Structuring custom case study solution

Included Health: A Vision for Integrated Care in America custom case study solution

Future-proofing Roche: Transforming for agility and empowerment custom case study solution

Claw and Kitty: Gripping a Potential Expansion custom case study solution

Shall Indian Railways Reform, Collaborate and Perform with Startups? custom case study solution

Investec South Africa CSI: Harnessing Crisis to Scale Up Delivery and Impact custom case study solution

BeefLedger: Cross-Border Beef Supply Chain Based on Blockchain Technology custom case study solution

Alibaba's IPO Dilemma: Hong Kong or New York? custom case study solution

Denka Chemicals custom case study solution

Nomura Securities--2002 custom case study solution

Shanghai Interior Automotive Door System: Running a Manufacturing Operation in China custom case study solution